Abstract:Although extracellular host DNA (ecDNA) levels in CF airways were linked to airflow obstruction and recombinant DNAse therapy is beneficial for CF patients, it remains incompletely understood whether ecDNA also leads to an autoimmune response. Here we hypothesized that chronic presence of DNA in CF airways triggers the production of autoantibodies targeting host human DNA. We measured the levels of IgA autoantibodies recognising host double-stranded (ds) DNA in the blood and sputum samples of CF patients and only sera of controls subjects and patients suffering from rheumatoid arthritis and systemic lupus erythematosus (SLE) that served as non-CF, autoimmune disease cohorts. We found that concentrations of anti-dsDNA IgA, but not IgG, autoantibodies in the circulation were significantly elevated in adult CF patients compared to age-matched, control subjects. Systemic levels of anti-dsDNA IgA antibodies negatively correlated with FEV1% predicted, a measure of lung function, in CF patients. Anti-dsDNA IgA autoantibodies were also detected in CF sputa but sputum levels did not correlate with the degree of airway obstruction or sputum levels of DNA. We also found elevated autoantibody levels in CF children as 76.5% of CF patients younger than 10 years and 87.5% of CF patients 10-21 years had higher blood anti-dsDNA IgA levels than the highest value found in healthy control adults. Overall, our results detect elevated systemic anti-dsDNA IgA autoantibody levels in CF adults, teenagers and young children. We speculate that the appearance of an autoimmune response against host DNA in CF is an early event potentially contributing to disease pathogenesis. Highlights CF serum contains elevated levels of anti-dsDNA IgA, but not anti-dsDNA IgG, autoantibodies Anti-dsDNA IgA autoantibody levels in serum correlate with airflow obstruction in CF Anti-dsDNA IgA autoantibodies are detected in CF sputum but do not correlate with airflow obstruction Anti-dsDNA IgA autoantibodies are also elevated in the blood of the majority of CF toddlers and youth.

Autoantibodies Against Bactericidal Permeability-Increasing Protein In Patients With Cystic Fibrosis

Targeting IgG Autoantibodies for Improved Cytotoxicity of Bactericidal Permeability Increasing Protein in Cystic Fibrosis

Low-Avidity Autoantibodies against Bactericidal/Permeability-Increasing Protein Occur in Gram-Negative and Gram-Positive Bacteremia

Bactericidal Permeability-Increasing Protein (Bpi) Is An Important Antigen For Antineutrophil Cytoplasmic Autoantibodies (Anca) In Vasculitis

Pseudomonas aeruginosa in cystic fibrosis: pyocyanin negative strains are associated with BPI-ANCA and progressive lung disease

Cystic fibrosis autoantibody signatures associate with Staphylococcus aureus lung infection or cystic fibrosis-related diabetes

Antineutrophil Cytoplasmic Antibody–Associated Lung Fibrosis

Clinical significance of BPI-ANCA detecting in COPD patients with Pseudomonas aeruginosa colonization

IgA autoantibodies directed against self DNA are elevated in cystic fibrosis and associated with more severe lung dysfunction

Antineutrophil Cytoplasmic Autoantibodies in Patients with Systemic Lupus Erythematosus Recognize a Novel 69 Kda Target Antigen of Neutrophil Granules.

Scorpionfish BPI is highly active against multiple drug-resistant Pseudomonas aeruginosa isolates from people with cystic fibrosis

The relationship of clinical and inflammatory markers to outcome in stable patients with cystic fibrosis

Clinical Analysis of Diffusive Interstitial Lung Diseases with Positive Anti-Neutrophil Cytoplasmic Antibody

Immunomodulatory function of the cystic fibrosis modifier gene BPIFA1

Anti-Endothelial Cell Antibodies in Antineutrophil Cytoplasmic Antibodies Negative Pauci-Immune Crescentic Glomerulonephritis

Antineutrophil Cytoplasmic Autoantibodies (ANCA) and Their Target Antigens in Chinese Patients with Lupus Nephritis

Anti-neutrophil cytoplasmic antibodies (ANCA) and inflammatory bowel diseases in Chinese

Anti-C1q autoantibodies are frequently detected in patients with systemic sclerosis associated with pulmonary fibrosis

Detection Rate and Antigenic Specificities of Antineutrophil Cytoplasmic Antibodies in Chinese Patients with Clinically Suspected Vasculitis

Azurocidin is A Novel Antigen for Anti-Neutrophil Cytoplasmic Autoantibodies (anca) in Systemic Vasculitis

Antibodies Against Linear Epitopes on Goodpasture Autoantigen in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.